Answers are grounded in this paper and cite their sources.
A tri-federal initiative arising out of the Cancer Moonshot has resulted in the formation of a program to utilize advanced genomic and proteomic expression platforms on high-quality human biospecimens in near-real-time in order to identify potentially actionable therapeutic molecular targets, study the relationship of molecular findings to cancer treatment outcomes, and accelerate novel clinical trials with biomarkers of prognostic and predictive value.
No takes yet. Share an insight, caveat, or question.
Fiore et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: